FDA Approves LAMOTRIGINE — Amneal Pharmaceuticals of New York LLC

**Amneal Pharmaceuticals of New York LLC announced the approval of its Abbreviated New Drug Application (ANDA200828) for the generic oral drug lamotrigine, adding a compelling option to the market.** The approval positions the company to capture a significant revenue stream by offering a cost-effective alternative to the branded prescription.